Route of administration-dependent anti-inflammatory effect of liposomal alendronate

Journal of Controlled Release

Volumn 148, Issue 2, 2010, Pages 226-233

  Haber, E ^a   Afergan, E ^a   Epstein, H ^a   Gutman, D ^a   Koroukhov, N ^a   Ben David, M ^a   Schachter, M ^b   Golomb, G ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Alendronate; Biodistribution; Drug delivery; Endometriosis; Inflammation; Liposomes; Macrophages; Monocytes; Restenosis

Indexed keywords

ALENDRONATE; BIODISTRIBUTIONS; ENDOMETRIOSIS; INFLAMMATION; MONOCYTES; RESTENOSIS;

ANIMALS; DRUG DELIVERY; LIPOSOMES; MACROPHAGES; PATHOLOGY; PHOSPHOLIPIDS;

BODY FLUIDS;

ALENDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; DRUG MEGADOSE; LIPOSOMAL DELIVERY; LOW DRUG DOSE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS;

ALENDRONATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAROTID STENOSIS; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; ENDOMETRIOSIS; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LIPOSOMES; MACROPHAGES, PERITONEAL; MONOCYTES; RABBITS; RATS; TISSUE DISTRIBUTION;

EID: 78649323529     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.08.030     Document Type: Article

References (54)

1. Allen T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 1994, 15:215-220.
2. Buiting A.M., Zhou F., Bakker J.A., van Rooijen N., Huang L. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach. J. Immunol. Methods 1996, 192:55-62.
3. Buiting A.M.J., Derover Z., Claassen E., Vanrooijen N. In-vivo distribution of particulate antigens and liposomes in murine spleen - a possible role in the humoral immune-response. Immunobiology 1993, 188:13-22.
4. Van Rooijen N., Kors N., Test M. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 1990, 260:215-222.
5. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1994, 174:83-93.
6. Van Rooijen N. Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages. J. Drug Target. 2008, 16:529-534.
7. Epstein-Barash H., Gutman D., Markovsky E., Mishan-Eisenberg G., Koroukhov N., Szebeni J., Golomb G. Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: Internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death. J. Control. Release 2010, 146:182-195.
8. Moghimi S.M., Hunter A.C. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm. Res. 2001, 18:1-8.
9. Allen T.M., Hansen C. Pharmacokinetics of stealth versus conventional liposomes - effect of dose. Biochem. Biophys. Acta 1991, 1068:133-141.
10. Allen T.M., Hansen C.B., Demenezes D.E.L. Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 1995, 16:267-284.
11. Harashima H., Hiraiwa T., Ochi Y., Kiwada H. Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. J. Drug Target. 1995, 3:253-261.
12. Juliano R.L., Stamp D. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Commun. 1975, 63:651-658.
13. Richards P.J., Williams B.D., Williams A.S. Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate. Rheumatology 2001, 40:978-987.
14. Slegers T.P., van Rooijen N., van Rij G., van der Gaag R. Delayed graft rejection in pre-vascularised corneas after subconjunctival injection of clodronate liposomes. Curr. Eye Res. 2000, 20:322-324.
15. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., Schwendener R.A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 2006, 95:272-281.
16. Cohen-Sela E., Dangoor D., Epstein H., Gati I., Danenberg H.D., Golomb G., Gao J. Nanospheres of a bisphosphonate attenuate intimal hyperplasia. J. Nanosci. Nanotechnol. 2006, 6:3226-3234.
17. Cohen-Sela E., Rosenzweig O., Gao J., Epstein H., Gati I., Reich R., Danenberg H.D., Golomb G. Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosis. J. Control. Release 2006, 113:23-30.
18. Danenberg H.D., Fishbein I., Epstein H., Waltenberger J., Moerman E., Monkkonen J., Gao J., Gathi I., Reichi R., Golomb G. Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery. J. Cardiovasc. Pharmacol. 2003, 42:671-679.
19. Danenberg H.D., Fishbein I., Gao J., Monkkonen J., Reich R., Gati I., Moerman E., Golomb G. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 2002, 106:599-605.
20. Danenberg H.D., Golomb G., Groothuis A., Gao J., Epstein H., Swaminathan R.V., Seifert P., Edelman E.R. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation 2003, 108:2798-2804.
21. Haber E., Danenberg H.D., Koroukhov N., Ron-El R., Golomb G., Schachter M. Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Hum. Reprod. 2009, 24:398-407.
22. Allen T.M., Hansen C.B., Guo L.S.S. Subcutaneous administration of liposomes - a comparison with the intravenous and intraperitoneal routes of injection. Biochem. Biophys. Acta 1993, 1150:9-16.
23. Afergan E., Epstein H., Koroukhov N., Klein M., Litchi A., Mishani E., Golomb G. Biodistribution and imaging studies of Ga-67-labeled liposomes in rabbits with a vascular injury. J. Drug Del. Sci. Technol. 2009, 19:263-268.
24. Monkkonen J., Ylitalo P. The tissue distribution of clodronate (dichloromethylene bisphosphonate) in mice - the effects of vehicle and the route of administration. Eur. J. Drug Metab. Pharmacokinet. 1990, 15:239-243.
25. Epstein H., Gutman D., Cohen-Sela E., Haber E., Elmalak O., Koroukhov N., Danenberg H.D., Golomb G. Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization. AAPS J. 2008, 10:505-515.
26. Epstein H., Berger V., Levi I., Eisenberg G., Koroukhov N., Gao J.C., Golomb G. Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. J. Control. Release 2007, 117:322-332.
27. Afergan E., Epstein H., Dahan R., Koroukhov N., Rohekar K., Danenberg H.D., Golomb G. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J. Control. Release 2008, 132:84-90.
28. Golomb G., Fishbein I., Banai S., Mishaly D., Moscovitz D., Gertz S.D., Gazit A., Poradosu E., Levitzki A. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis 1996, 125:171-182.
29. Lin J.H. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996, 18:75-85.
30. Lin J.H., Duggan D.E., Chen I.W., Ellsworth R.L. physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory-animals. Drug Metab. Dispos. 1991, 19:926-932.
31. Daleke D.L., Hong K.L., Papahadjopoulos D. Endocytosis of liposomes by macrophages - binding, acidification and leakage of liposomes monitored by a new fluorescence assay. Biochem. Biophys. Acta 1990, 1024:352-366.
32. Miller C.R., Bondurant B., McLean S.D., McGovern K.A., O'Brien D.F. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. Biochemistry 1998, 37:12875-12883.
33. Yoshimura T., Shono M., Imai K., Hong K.L. Kinetic-analysis of endocytosis and intracellular fate of liposomes in single macrophages. J. Biochem. 1995, 117:34-41.
34. Naito M., Nagai H., Kawano S., Umezu H., Zhu H., Moriyama H., Yamamoto T., Takatsuka H., Takei Y. Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J. Leukoc. Biol. 1996, 60:337-344.
35. Cohen-Sela E., Chorny M., Gutman D., Komemi S., Koroukhov N., Golomb G. Characterization of monocytes-targeted nanocarriers biodistribution in leukocytes in ex-vivo and in-vivo models. Nano Biomed. Eng. 2010, 2:91-99.
36. Rodan G.A. Mechanisms of action of bisphosphonates. Annu. Rev. Pharmacol. Toxicol. 1998, 38:375-388.
37. Roelofs A.J., Thompson K., Gordon S., Rogers M.J. Molecular mechanisms of action of bisphosphonates: current status. Clin. Cancer Res. 2006, 12:6222s-6230s.
38. Kao Y.J., Juliano R.L. Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. Biochim. Biophys. Acta 1981, 677:453-461.
39. Epstein H., Afergan E., Moise T., Richter Y., Rudich Y., Golomb G. Number-concentration of nanoparticles in liposomal and polymeric multiparticulate preparations: empirical and calculation methods. Biomaterials 2006, 27:651-659.
40. Scherphof G.L., Kamps J.A. The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog. Lipid Res. 2001, 40:149-166.
41. Rahman Y.E., Cerny E.A., Patel K.R., Lau E.H., Wright B.J. Differential uptake of liposomes varying in size and lipid composition by parenchymal and kupffer cells of mouse liver. Life Sci. 1982, 31:2061-2071.
42. Gregory S.H., Wing E.J., Danowski K.L., van Rooijen N., Dyer K.F., Tweardy D.J. IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. J. Immunol. 1998, 160:6056-6061.
43. Bautista A.P., Skrepnik N., Niesman M.R., Bagby G.J. Elimination of macrophages by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-induced priming of Kupffer cells. J. Leukoc. Biol. 1994, 55:321-327.
44. Van Rooijen N., Sanders A. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology 1996, 23:1239-1243.
45. Fukuda D., Shimada K., Tanaka A., Kawarabayashi T., Yoshiyama M., Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J. Am. Coll. Cardiol. 2004, 43:18-23.
46. Gagne D., Rivard M., Page M., Shazand K., Hugo P., Gosselin D. Blood leukocyte subsets are modulated in patients with endometriosis. Fertil. Steril. 2003, 80:43-53.
47. Cohen-Sacks H., Najajreh Y., Tchaikovski V., Gao G., Elazer V., Dahan R., Gati I., Kanaan M., Waltenberger J., Golomb G. Novel PDGF beta R antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther. 2002, 9:1607-1616.
48. Godin B., Sakamoto J.H., Serda R.E., Bouamrani A., Ferrari M. Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol. Sci. 2010, 31:199-205.
49. Simon D.I., Chen Z.P., Seifert P., Edelman E.R., Ballantyne C.M., Rogers C. Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J. Clin. Invest. 2000, 105:293-300.
50. Tanaka H., Sukhova G.K., Swanson S.J., Clinton S.K., Ganz P., Cybulsky M.I., Libby P. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993, 88:1788-1803.
51. Hancock W.W., Adams D.H., Wyner L.R., Sayegh M.H., Karnovsky M.J. Cd4 (+) mononuclear-cells induce cytokine expression, vascular smooth-muscle cell-proliferation, and arterial-occlusion after endothelial injury. Am. J. Pathol. 1994, 145:1008-1014.
52. Hanke H., Hassenstein S., Ulmer A., Kamenz J., Oberhoff M., Haase K.K., Baumbach A., Gown A.M., Karsch K.R. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur. Heart J. 1994, 15:691-698.
53. Libby P., Schwartz D., Brogi E., Tanaka H., Clinton S.K. A cascade model for restenosis - a special case of atherosclerosis progression. Circulation 1992, 86:47-52.
54. Lebovic D.I., Mueller M.D., Taylor R.N. Immunobiology of endometriosis. Fertil. Steril. 2001, 75:1-10.